See All Slides - tctmd.com

Slides

Presentation TCT 2013

Technqiues to Reduce the Frequency of Side Branch Stenting

Presenter: Yves Louvard

October 30, 2013

Presentation TCT 2013

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Presenter: Fernando Alfonso

October 30, 2013

Presentation TCT 2013

Management of Post-EVAR Endoleaks

Presenter: Mahmood Razavi

October 30, 2013

Presentation TCT 2013

Case Presentation 1: My Most Difficult Retrograde Approach Case in 2013

Presenter: R. Michael Wyman

October 30, 2013

Presentation TCT 2013

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Presenter: Henrique Carvalho

October 30, 2013

Presentation TCT 2013

Treatment of Cardiogenic Shock: Less Clear than Ever?

Presenter: Holger Thiele

October 30, 2013

Presentation TCT 2013

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

Presenter: Mitchell Krucoff

October 30, 2013

Presentation TCT 2013

ACCESS EU Insights: Are the Randomized Trial Results Translatable?

Presenter: Olaf Franzen

October 30, 2013

Presentation TCT 2013

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Presenter: Christy Foreman

October 30, 2013

Presentation TCT 2013

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Presenter: Stephan Windecker

October 30, 2013

Advertisement

Slides

Technqiues to Reduce the Frequency of Side Branch Stenting

RIBS V: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty vs. Everolimus-Eluting Stents in Bare Metal In-Stent Restenosis

Management of Post-EVAR Endoleaks

Case Presentation 1: My Most Difficult Retrograde Approach Case in 2013

Flash Lecture #2: Renal Denervation: Summary of Clinical Evidence

Treatment of Cardiogenic Shock: Less Clear than Ever?

Problem Statement: The Good, the Bad, and the Ugly of Clinical Research in 2013

ACCESS EU Insights: Are the Randomized Trial Results Translatable?

Keynote Address: FDA-CDRH in the Next Decade – A Vision for Change

Motion: PFO Occlusion in a Patient Presenting with Stroke Reduces Recurrence - For: The Evidence Base is Clear Enough – All PFOs Should be Closed!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content